Market Snapshot

High-signal KPIs designed for executive scanning.

Indicative snapshot. Request sample for full model outputs.

Market Size (latest)

—

— vs. prior year

CAGR

—

Forecast window: —

Forecast Period

—–—

Base years: —–—

Coverage Depth

—

Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

Market Overview

Transcatheter pulmonary valve (TPV) implantation is a catheter-based therapy that treats dysfunctional right-ventricular outflow tract (RVOT) conduits or native outflow tracts in patients with congenital heart disease (CHD)—particularly tetralogy of Fallot, pulmonary atresia, and truncus arteriosus—who would otherwise face repeat open-heart surgery. This minimally invasive approach delivers a bioprosthetic valve on a balloon-expandable or self-expanding stent via femoral or jugular venous access, restoring competence and reducing right-sided pressures. Advantages include shorter hospital stays, rapid recovery, lower infection risk, and cost savings compared to redo sternotomy. The increasing survival of CHD patients into adulthood, device innovations that treat larger native outflow tracts, and expanding reimbursement are driving market growth.

Market Size and Forecast

Year	Market Value (USD Billion)	Notes
2019	0.42	Early adoption dominated by Medtronic Melody valve in surgically placed conduits
2024	0.88	Five‑year CAGR 15.4 % (2019–2024); launch of second‑generation valves and wider regional approvals
2031	2.05	Seven‑year CAGR 12.8 % (2024–2031); high‑adoption scenario USD 2.4 billion if large‑diameter native‑RVOT devices gain global clearance

Adoption outlook – Annual TPV implant volumes are expected to rise from approximately 12,500 in 2024 to over 30,000 by 2031 as adult congenital heart (ACH) programs expand and device size ranges increase.

Primary Market Drivers

Rising ACH population – >90 % of CHD infants now survive to adulthood, creating a growing re‑intervention pool.
Avoidance of repeat sternotomy – Each surgical redo carries incremental morbidity; TPV offers a lower‑risk alternative.
Valve technology maturation – Self‑expanding and balloon‑expandable designs cover diameters 14 – 32 mm, addressing diverse anatomies.
Procedural cost savings – Studies show 20–30 % lower total hospital cost versus surgical valve replacement.
Reimbursement expansion – U.S. Medicare NTAP coverage, EU DRG alignment, and Japanese NHI listing boost adoption.

Market Challenges

Endocarditis risk – TPV bioprostheses have higher infective endocarditis incidence than surgical homografts.
Anatomical eligibility – Up to 60 % of native RVOT anatomies still unsuitable for current devices.
High device cost – Valves priced USD 23–35 k hinder access in low‑income regions.
Radiation exposure – Longer fluoroscopy times vs. surgical visualization.
Training requirements – Need for hybrid cath‑surgical skills and 3D imaging platforms.

Competitive Landscape

Company / Product	2024 Share	Strengths	Recent Moves
Medtronic – Melody / Harmony	57 %	First‑in‑class balloon & self‑expanding TPVs; >100k implants	Harmony™ TPV 25 & 30 mm received CE‑MDR approval (Q4 2024)
Edwards Lifesciences – SAPIEN Pulmonic	24 %	Balloon‑expandable valve adaptable to larger conduits	FDA IDE expansion for 35 mm size (Q1 2025)
Venus MedTech – VenusP‑Valve	8 %	Large‑diameter self‑expanding device for native RVOT	Achieved CE mark (Q1 2025); China NMPA reimbursement inclusion
JenaValve – Trilogy Pulmonic (pipeline)	–	Tri‑leaflet nitinol frame targeting severe regurgitation	Initiated pivotal ALIGN‑Pulmonic trial (Q2 2024)
Others (Meril, Xeltis, regional OEMs)	11 %	Emerging bioresorbable & polymer‑leaflet technologies	Pre‑clinical studies on polymeric leaflet TPVs

Detailed Market Segmentation

Segment	2024 Share	CAGR ’24–’31
By Valve Type
Balloon‑Expandable	XX%	11.5 %
Self‑Expanding	XX%	XX%
By Patient Group
Surgically Placed Conduits	XX%	XX%
Native RVOT	XX%	15.4 %
By End User
Adult Congenital Heart (ACH) Centers	51 %	XX%
Pediatric Cardiology Hospitals	XX%	12.1 %
Academic & Research Hospitals	XX%	11.6 %

Regional Analysis

North America (41 %) – Mature reimbursement; >120 TPV centers; Harmony adoption rising.
Europe (XX%) – Germany, UK, France drive volume; CE‑MDR approvals spur valve diversity.
Asia‑Pacific (XX%) – Fastest CAGR 15.7 %; China and Japan ramp ACH programs.
Latin America (XX %) – Brazil & Mexico pilot TPV within national SUS/IMSS networks.
Middle East & Africa (XX %) – Gulf states fund ACH hubs; South Africa establishes first TPV program.

Technology & Innovation

Large‑diameter self‑expanding nitinol frames treat native RVOT up to 34 mm.
Polymeric & tissue‑engineered leaflets target improved durability & reduced calcification.
3D rotational angiography & CT overlay enhances procedural planning.
Cerebral embolic protection trials aim to cut stroke risk.
Next‑gen delivery catheters with steerable sheaths reduce fluoroscopy time.

Regulatory Environment

FDA HDE & PMA pathways – Melody under HDE; Harmony received PMA (2023).
CE‑MDR drives post‑market clinical follow‑up; 2024 approvals under new rules.
China NMPA fast‑track for domestic TPVs addressing native RVOT.
ISO 5840‑3:2024 sets performance testing for transcatheter pulmonary valves.

Recent Developments (Q4 2023 – Q2 2025)

Medtronic Harmony 30 mm launched in EU & U.S. (Q4 2024).
Edwards SAPIEN Pulmonic 35 mm began pivotal IDE cohort (Q1 2025).
VenusP‑Valve obtained CE mark & first EU implants (Q1 2025).
3D‑printed patient‑specific RVOT modelling adopted by five major ACH centers (Q2 2024).
JenaValve secured €40 m funding for Trilogy Pulmonic trial expansion (Q4 2024).

Strategic Outlook

Cardiology networks should establish ACH referral pathways to centralize TPV expertise. Manufacturers must expand size ranges and validate long-term durability to penetrate the native RVOT segment. Payers are encouraged to align DRGs to acknowledge reduced hospital stays and re-intervention costs.

Methodology

Clearview Market Insights synthesized OEM shipment data, implant registry statistics, and 82 expert interviews from 17 countries. Forecasts take into account CHD prevalence, ACH program growth, valve-in-valve cycles, and reimbursement trajectories.

About Clearview Market Insights

Clearview Market Insights delivers forward‑looking intelligence in structural heart, congenital cardiology, and catheter‑based therapies.

Unlock the executive summary.

Request the sample to review key questions answered.

See what’s included.

Request sample for scope, definitions and segmentation.

Medtronic plc
Edwards Lifesciences Corporation
Boston Scientific Corporation
Abbott Laboratories
Artivion Inc.
Braile Biomedica
JenaValve Technology Inc.
Venus Medtech (Hangzhou) Inc.
LivaNova PLC
Xeltis AG

Competitive Dashboard Preview

Shortlist strategic accounts and benchmark positioning.

Loading…

Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.

Refine View

Geography Segment Sub-segment

—

Request A Custom Cut

Opportunity Index

Directional signals for prioritization and scenario framing.

Interactive

Need a board-ready slide? .

Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Global Transcatheter Pulmonary Valve (TPV) Market Report

1. Global Transcatheter Pulmonary Valve (TPV) Market Research Report
1. 1.1 Study Objectives
2. 1.2 Global Transcatheter Pulmonary Valve (TPV) Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Global Transcatheter Pulmonary Valve (TPV) Market Research Report - Preface
1. 2.1 Global Transcatheter Pulmonary Valve (TPV) Market Research Report – Detailed Scope and Definitions
  1. 2.1.1 By Valve Type
  2. 2.1.2 By Patient Group
  3. 2.1.3 By End User
  4. 2.1.4 By Region
3. Global Transcatheter Pulmonary Valve (TPV) Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Valve Type, By Patient Group, By End User, By Country
3. 3.3. Opportunities – By Valve Type, By Patient Group, By End User, By Country
4. 3.4. Trends – By Valve Type, By Patient Group, By End User, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Global Transcatheter Pulmonary Valve (TPV) Market Research Report – DROTs Impact Analysis

1. 4. Global Transcatheter Pulmonary Valve (TPV) Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031

5. Global Transcatheter Pulmonary Valve (TPV) Market, By Valve Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Balloon Expandable
2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 5.2 Self Expanding
7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Global Transcatheter Pulmonary Valve (TPV) Market, By Patient Group, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Surgically Placed Conduits
2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 6.2 Native RVOT
7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Global Transcatheter Pulmonary Valve (TPV) Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 Adult Congenital Heart
2. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
3. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
4. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 7.2 Pediatric Cardiology Hospitals
7. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
9. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
11. 7.3 Academic & Research Hospitals
12. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
13. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
14. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
15. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031

8. Global Transcatheter Pulmonary Valve (TPV) Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 North America
  1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  8.2 Europe
  1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  8.3 Asia-Pacific
  1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  8.4 Latin America
  1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  8.5 Middle East and Africa
  1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  8.6 Global Transcatheter Pulmonary Valve (TPV) Market - Opportunity Analysis Index, By Valve Type, By Patient Group, By End User, and Region, 2024 - 2031

9. North America Global Transcatheter Pulmonary Valve (TPV) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 9.1 By Valve Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.1.1 Balloon Expandable
  2. 9.1.2 Self Expanding
  9.2 By Patient Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.2.1 Surgically Placed Conduits
  2. 9.2.2 Native RVOT
  9.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.3.1 Adult Congenital Heart
  2. 9.3.2 Pediatric Cardiology Hospitals
  3. 9.3.3 Academic & Research Hospitals
  9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.4.1 United States
  2. 9.4.2 Canada
2. 9.5 North America Global Transcatheter Pulmonary Valve (TPV) Market – Opportunity Analysis Index, By Valve Type, By Patient Group, By End User, and Country, 2024 - 2031
3. 9.6 Regional Trends Analysis
4. 9.7 North America Global Transcatheter Pulmonary Valve (TPV) Market Research Report - Company Profiles
  1. 9.7.1 Company 1 (United States)
  2. 9.7.2 Company 2 (Canada)
  3. 9.7.3 Company 3 (Canada)
10. Europe Global Transcatheter Pulmonary Valve (TPV) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 10.1 By Valve Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.1.1 Balloon Expandable
  2. 10.1.2 Self Expanding
  10.2 By Patient Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.2.1 Surgically Placed Conduits
  2. 10.2.2 Native RVOT
  10.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.3.1 Adult Congenital Heart
  2. 10.3.2 Pediatric Cardiology Hospitals
  3. 10.3.3 Academic & Research Hospitals
  10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.4.1 Germany
  2. 10.4.2 United Kingdom
  3. 10.4.3 France
  4. 10.4.4 Spain
  5. 10.4.5 Italy
  6. 10.4.6 Russia
  7. 10.4.7 Netherlands and Rest of Europe
2. 10.5 Europe Global Transcatheter Pulmonary Valve (TPV) Market – Opportunity Analysis Index, By Valve Type, By Patient Group, By End User, and Country, 2024 - 2031
3. 10.6 Regional Trends Analysis
4. 10.7 Europe Global Transcatheter Pulmonary Valve (TPV) Market Research Report - Company Profiles
  1. 10.7.1 Company 1 (Germany)
  2. 10.7.2 Company 2 (United Kingdom)
  3. 10.7.3 Company 3 (United Kingdom)
11. Asia-Pacific Global Transcatheter Pulmonary Valve (TPV) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 11.1 By Valve Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.1.1 Balloon Expandable
  2. 11.1.2 Self Expanding
  11.2 By Patient Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.2.1 Surgically Placed Conduits
  2. 11.2.2 Native RVOT
  11.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.3.1 Adult Congenital Heart
  2. 11.3.2 Pediatric Cardiology Hospitals
  3. 11.3.3 Academic & Research Hospitals
  11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.4.1 China
  2. 11.4.2 Japan
  3. 11.4.3 India
  4. 11.4.4 South Korea
  5. 11.4.5 Australia & New Zealand
  6. 11.4.6 ASEAN
  7. 11.4.7 Rest of Asia-Pacific
2. 11.5 Asia-Pacific Global Transcatheter Pulmonary Valve (TPV) Market – Opportunity Analysis Index, By Valve Type, By Patient Group, By End User, and Country, 2024 - 2031
3. 11.6 Regional Trends Analysis
4. 11.7 Asia-Pacific Global Transcatheter Pulmonary Valve (TPV) Market Research Report - Company Profiles
  1. 11.7.1 Company 1 (China)
  2. 11.7.2 Company 2 (Japan)
  3. 11.7.3 Company 3 (Japan)
12. Latin America Global Transcatheter Pulmonary Valve (TPV) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 12.1 By Valve Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.1.1 Balloon Expandable
  2. 12.1.2 Self Expanding
  12.2 By Patient Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.2.1 Surgically Placed Conduits
  2. 12.2.2 Native RVOT
  12.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.3.1 Adult Congenital Heart
  2. 12.3.2 Pediatric Cardiology Hospitals
  3. 12.3.3 Academic & Research Hospitals
  12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.4.1 Brazil
  2. 12.4.2 Mexico
  3. 12.4.3 Argentina
  4. 12.4.4 Peru
  5. 12.4.5 Colombia
  6. 12.4.6 Rest of Latin America
2. 12.5 Latin America Global Transcatheter Pulmonary Valve (TPV) Market – Opportunity Analysis Index, By Valve Type, By Patient Group, By End User, and Country, 2024 - 2031
3. 12.6 Regional Trends Analysis
4. 12.7 Latin America Global Transcatheter Pulmonary Valve (TPV) Market Research Report - Company Profiles
  1. 12.7.1 Company 1 (Brazil)
  2. 12.7.2 Company 2 (Mexico)
  3. 12.7.3 Company 3 (Mexico)
13. Middle East and Africa Global Transcatheter Pulmonary Valve (TPV) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 13.1 By Valve Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.1.1 Balloon Expandable
  2. 13.1.2 Self Expanding
  13.2 By Patient Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.2.1 Surgically Placed Conduits
  2. 13.2.2 Native RVOT
  13.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.3.1 Adult Congenital Heart
  2. 13.3.2 Pediatric Cardiology Hospitals
  3. 13.3.3 Academic & Research Hospitals
  13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.4.1 Saudi Arabia
  2. 13.4.2 UAE
  3. 13.4.3 South Africa
  4. 13.4.4 Egypt
  5. 13.4.5 Israel
  6. 13.4.6 Rest of Middle East and Africa
2. 13.5 Middle East and Africa Global Transcatheter Pulmonary Valve (TPV) Market – Opportunity Analysis Index, By Valve Type, By Patient Group, By End User, and Country, 2024 - 2031
3. 13.6 Regional Trends Analysis
4. 13.7 Middle East and Africa Global Transcatheter Pulmonary Valve (TPV) Market Research Report - Company Profiles
  1. 13.7.1 Company 1 (Saudi Arabia)
  2. 13.7.2 Company 2 (UAE)
  3. 13.7.3 Company 3 (UAE)
14. Competition Landscape
1. 14.1 Strategic Dashboard of Top Market Players
2. 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
  1. 14.2.1 Medtronic plc
  2. 14.2.2 Edwards Lifesciences Corporation
  3. 14.2.3 Boston Scientific Corporation
  4. 14.2.4 Abbott Laboratories
  5. 14.2.5 Artivion Inc.
  6. 14.2.6 Braile Biomedica
  7. 14.2.7 JenaValve Technology Inc.
  8. 14.2.8 Venus Medtech (Hangzhou) Inc.
  9. 14.2.9 LivaNova PLC
  10. 14.2.10 Xeltis AG

15. Data Collection Method and Research Approach

16. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.

Triangulated Sizing

Bottom-up, top-down, and peer benchmarks reconciled by analysts.

Primary + Secondary Research

Executive interviews combined with validated public and paid sources.

Scenario & Sensitivity

Base, bull and bear cases to stress-test strategic moves.

Book A Consultation

Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.

Global LED Lip Masks Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30115 Dec. 1, 2025

$3600.00 single user

View report →

Global Advanced Musculoskeletal Care Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30116 Dec. 1, 2025

$3600.00 single user

View report →

Global Under-Arm Exoskeletons Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI0112 Dec. 1, 2025

$3600.00 single user

View report →

Global Wearable Light Therapy Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30112 Nov. 30, 2025

$3600.00 single user

View report →

Global Light-Powered Joint Support Systems Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30114 Nov. 30, 2025

$3600.00 single user

View report →

Global Wearable Medical-Grade Cold Lasers Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI3011 Nov. 30, 2025

$3600.00 single user

View report →

Global Dual Microcurrent Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30113 Nov. 30, 2025

$3600.00 single user

View report →

Global Targeted Air Compression Therapies Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI2711 Nov. 27, 2025

$3600.00 single user

View report →

Global Wearable Light-Emitting Diodes (LEDs) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI27111 Nov. 27, 2025

$3600.00 single user

View report →

Global Robotic Hand Assistance Solutions Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI2611 Nov. 26, 2025

$3600.00 single user

View report →

Istanbul Hair Transplant Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI26081 Aug. 26, 2025

$3600.00 single user

View report →

Global Osteo-Odonto-Keratoprosthesis (OOKP) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI1008 Aug. 10, 2025

$3600.00 single user

View report →

Ready to move from data to decision?

Get the report, request a sample, or book a consultative briefing.

Buy Report Talk To An Analyst

Global Transcatheter Pulmonary Valve (TPV) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

Market Snapshot

Insights

Segmentation Explorer

Table Of Contents

Global Transcatheter Pulmonary Valve (TPV) Market Report

Methodology & Credibility

Related Reports